Advertisement

Dosierung von Neuroleptika

  • B. Woggon
Conference paper
Part of the Tropon-Symposium book series (BAYERZNS, volume 2)

Zusammenfassung

Seit der Entdeckung des ersten Neuroleptikums sind 34 Jahre vergangen. Inzwischen ist gesichert, daß Neuroleptika antipsychotisch wirken und daß sie den Verlauf der Schizophrenie durch ihre rückfallverhütende Wirkung beeinflussen können.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Aubree JC, Lader MH (1980) High and very high dosage antipsychotics: A critical review. J Clin Psychiatry 41: 341–350PubMedGoogle Scholar
  2. Baldessarini RJ, Davis JM (1980) What is the best maintenance dose of neuroleptics in schizophrenia? Psychiatry Res 3: 115–122PubMedCrossRefGoogle Scholar
  3. Baldessarini RJ, Katz B, Cotton P (1984) Dissimilar dosing with high-potency and low-potency neuroleptics. Am J Psychiatry 141: 748–752PubMedGoogle Scholar
  4. Clark ML, Ramsey HR, Rahhal DK, Serafetinides EA, Wood FD, Costiloe JP (1972) Chlorpromazine in chronic schizophrenia. Arch Gen Psychiatry 27: 479–483PubMedCrossRefGoogle Scholar
  5. Davis JM, Schaffer CB, Killian GA, Kinard C, Chan C (1980) Important issues in the drug treatment of schizophrenia. Schizophren Bull 6: 70–87Google Scholar
  6. Gardos G (1974) Are antipsychotic drugs interchangeable ? J Nery Ment Dis 159:343–348 Gardos G, Cole JO (1973) The importance of dosage in antipsychotic drug administration — A review of dose-response studies. Psychopharmacologia (Berl) 29: 221–230Google Scholar
  7. Lehmann E, Quadbeck H, Tegeler J, Fararuni M, Heinrich K (1980) Wirkungsdifferenzen bei Hoch-und Standarddosierung von Fluphenazin-Decanoat in Abhängigkeit von Patienten-Merkmalen. Pharmacopsychiatry 13: 117–129CrossRefGoogle Scholar
  8. McIntyre IM, Gershon S (1985) Interpatient variations in antipsychotic therapy. J Clin Psychiatry 46 /5: 3–5PubMedGoogle Scholar
  9. Nedopil N, Eben E, Klein H, Krüger R, Rüther E, Schmauss M (1985) High-dosage neuroleptic therapy for acute schizophrenic patients — Two double-blind studies with benperidol. Pharmacopsychiatry 18: 63–66PubMedCrossRefGoogle Scholar
  10. Richelson E (1984) Neuroleptic affinities for human brain receptors and their use in predicting adverse effects. J Clin Psychiatry 45: 331–336PubMedGoogle Scholar
  11. Rimon R, Averbuch I, Rozick P et al. (1981) Serum and CSF levels of haloperi dol by radioimmunoassay and radioreceptor assay during high-dose therapy of resistant schizophrenic patients. Psychopharmacology 73: 197–199PubMedCrossRefGoogle Scholar
  12. Sedvall G, Farde L, Persson A, Wiesel FA (1986) Imaging of neurotransmitter receptors in the living human brain. Arch Gen Psychiatry 43: 995–1005PubMedCrossRefGoogle Scholar
  13. Wode-Helgodt B, Borg S, Fyroe B, Sedvall G (1978) Clinical effects and drug concentrations in plasma and cerebrospinal fluid in psychotic patients treated with fixed doses of chlorpromazine. Acta Psychiatr Scand 58: 149–173PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • B. Woggon

There are no affiliations available

Personalised recommendations